Carolyn McAuliffe
Public Communications Contact presso AERIE PHARMACEUTICALS, INC.
Posizioni attive di Carolyn McAuliffe
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| AERIE PHARMACEUTICALS, INC. | Public Communications Contact | 13/09/2021 | - |
Storia della carriera di Carolyn McAuliffe
Precedenti posizioni note di Carolyn McAuliffe
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MASIMO CORPORATION | Public Communications Contact | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
Posizioni
| Public Communications Contact | 2 |
Settori
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MASIMO CORPORATION | Health Technology |
| Aziende private | 1 |
|---|---|
Aerie Pharmaceuticals, Inc.
 Aerie Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105. The company was founded by David L. Epstein, Casey C. Kopczynski, Thomas J. van Haarlem, and Eric J. Toone on January 1, 2005 and is headquartered in Durham, NCForth Worth, TX. | Health Technology |
- Borsa valori
- Insiders
- Carolyn McAuliffe
- Esperienza
